On July 9, 2025, Dare Bioscience, Inc. held its annual stockholder meeting where stockholders approved four proposals, including an amendment to the 2022 Stock Incentive Plan, increasing shares by 600,000. Key director nominees were elected and Haskell & White LLP was ratified as the accounting firm for 2025.